Spineway (ALSPW) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.023x

Based on the latest financial reports, Spineway (ALSPW) has a cash flow conversion efficiency ratio of 0.023x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€538.00K ≈ $628.98K USD) by net assets (€23.86 Million ≈ $27.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Spineway fund operations to measure how many days the company can operate on defensive assets alone.

Spineway - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Spineway's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Spineway Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Spineway ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
QX Resources Ltd
AU:QXR
-0.084x
My Rewards International Ltd
AU:MRI
0.003x
INTL SCHOOL AUGS.AG NA ON
F:9JK
N/A
DSS Inc
NYSE MKT:DSS
-0.290x
CAQ Holdings Ltd
AU:CAQ
-0.001x
Reklaim Ltd
V:MYID
-0.299x
Rayong Wire Industries Public Company Limited
BK:RWI
-0.006x
Lucapa Diamond Company Ltd
AU:LOM
-0.039x

Annual Cash Flow Conversion Efficiency for Spineway (2011–2025)

The table below shows the annual cash flow conversion efficiency of Spineway from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see Spineway market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €23.06 Million
≈ $26.96 Million
€-163.00K
≈ $-190.56K
-0.007x +94.77%
2024-12-31 €24.24 Million
≈ $28.34 Million
€-3.27 Million
≈ $-3.83 Million
-0.135x +55.85%
2023-12-31 €19.05 Million
≈ $22.28 Million
€-5.83 Million
≈ $-6.81 Million
-0.306x -315.53%
2022-12-31 €22.01 Million
≈ $25.73 Million
€-1.62 Million
≈ $-1.89 Million
-0.074x +14.38%
2021-12-31 €20.88 Million
≈ $24.41 Million
€-1.79 Million
≈ $-2.10 Million
-0.086x -111.09%
2020-12-31 €10.02 Million
≈ $11.71 Million
€-408.00K
≈ $-476.99K
-0.041x +77.22%
2019-12-31 €6.49 Million
≈ $7.59 Million
€-1.16 Million
≈ $-1.36 Million
-0.179x +95.04%
2018-12-31 €945.00K
≈ $1.10 Million
€-3.41 Million
≈ $-3.99 Million
-3.608x -593.91%
2017-12-31 €1.77 Million
≈ $2.07 Million
€-922.00K
≈ $-1.08 Million
-0.520x -241.43%
2016-12-31 €1.30 Million
≈ $1.52 Million
€-198.00K
≈ $-231.48K
-0.152x -364.80%
2015-12-31 €3.02 Million
≈ $3.53 Million
€-99.00K
≈ $-115.74K
-0.033x +91.21%
2014-12-31 €4.62 Million
≈ $5.41 Million
€-1.72 Million
≈ $-2.01 Million
-0.373x -68.98%
2013-12-31 €5.12 Million
≈ $5.99 Million
€-1.13 Million
≈ $-1.32 Million
-0.221x -167.96%
2012-12-31 €1.16 Million
≈ $1.36 Million
€378.00K
≈ $441.92K
0.324x +172.35%
2011-12-31 €844.99K
≈ $987.88K
€-379.00K
≈ $-443.09K
-0.449x --

About Spineway

PA:ALSPW France Medical Instruments & Supplies
Market Cap
$5.11 Million
€4.37 Million EUR
Market Cap Rank
#28724 Global
#521 in France
Share Price
€0.12
Change (1 day)
+0.00%
52-Week Range
€0.12 - €0.23
All Time High
€1000000.00
About

Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The comp… Read more